BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22579619)

  • 1. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
    Nishida H; Hasuoka A; Arikawa Y; Kurasawa O; Hirase K; Inatomi N; Hori Y; Sato F; Tarui N; Imanishi A; Kondo M; Takagi T; Kajino M
    Bioorg Med Chem; 2012 Jun; 20(12):3925-38. PubMed ID: 22579619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
    Arikawa Y; Nishida H; Kurasawa O; Hasuoka A; Hirase K; Inatomi N; Hori Y; Matsukawa J; Imanishi A; Kondo M; Tarui N; Hamada T; Takagi T; Takeuchi T; Kajino M
    J Med Chem; 2012 May; 55(9):4446-56. PubMed ID: 22512618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening of potassium-competitive acid blockers.
    Kondo M; Kawamoto M; Hasuoka A; Kajino M; Inatomi N; Tarui N
    J Biomol Screen; 2012 Feb; 17(2):177-82. PubMed ID: 21940711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
    J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2'-piperidin)-1-ones as potassium-competitive acid blockers.
    Imaeda T; Ono K; Nakai K; Hori Y; Matsukawa J; Takagi T; Fujioka Y; Tarui N; Kondo M; Imanishi A; Inatomi N; Kajino M; Itoh F; Nishida H
    Bioorg Med Chem; 2017 Jul; 25(14):3719-3735. PubMed ID: 28522264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KFP-H008 blocks gastric acid secretion through inhibiting H
    Li CY; Su M; Yan YY; Zhou L; Ao LY; Fang WR; Li YM
    Eur J Pharmacol; 2017 Sep; 810():112-119. PubMed ID: 28629736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion.
    Nishida H; Fujimori I; Arikawa Y; Hirase K; Ono K; Nakai K; Inatomi N; Hori Y; Matsukawa J; Fujioka Y; Imanishi A; Fukui H; Itoh F
    Bioorg Med Chem; 2017 Jul; 25(13):3447-3460. PubMed ID: 28483454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives as potent potassium-competitive acid blockers.
    Wang X; Xu Y; Zong Z; Cai J; Chen C; Zhang Q; Sun X; Li J
    Bioorg Med Chem; 2022 Jun; 64():116765. PubMed ID: 35477061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands.
    Matsukawa J; Hori Y; Nishida H; Kajino M; Inatomi N
    Biochem Pharmacol; 2011 May; 81(9):1145-51. PubMed ID: 21371447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Brehm C; Buhr W; Palmer AM; Volz J; Simon WA
    Bioorg Med Chem; 2008 Jan; 16(1):536-41. PubMed ID: 17964794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action.
    Nishida H; Arikawa Y; Hirase K; Imaeda T; Inatomi N; Hori Y; Matsukawa J; Fujioka Y; Hamada T; Iida M; Nishitani M; Imanishi A; Fukui H; Itoh F; Kajino M
    Bioorg Med Chem; 2017 Jul; 25(13):3298-3314. PubMed ID: 28442261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
    Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
    Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides.
    Terauchi H; Tanitame A; Tada K; Nakamura K; Seto Y; Nishikawa Y
    J Med Chem; 1997 Jan; 40(3):313-21. PubMed ID: 9022797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
    Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrimidines as acid pump antagonists (APAs).
    Yoon YA; Park CS; Cha MH; Choi H; Sim JY; Kim JG
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5735-8. PubMed ID: 20810280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-Potassium (H(+)/K(+)) ATPases: Properties and Roles in Health and Diseases.
    Sakai H; Fujii T; Takeguchi N
    Met Ions Life Sci; 2016; 16():459-83. PubMed ID: 26860309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.